Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Read more from SRI
-
Major NIH study helps families manage sleep and screentime
SRI Fellow Fiona Baker: Longitudinal research like the SRI-supported ABCD study is crucial for understanding how modern life shapes developing brains.
-
SRI and Global Innovation Labs deliver deep tech solutions to regional markets
The strategic partnership represents the next-gen approach to bridging science with rapid go-to-market strategies.
-
Achieving the potential of autonomous drones
Leveraging SRI navigation technology, Entropy Robotics aims to create safe, resilient autonomous platforms for defense, livestock management, disaster recovery, and much more.